QC
Quadrature Capital Portfolio holdings
AUM
$5.81B
1-Year Return
34.32%
This Quarter Return
+21.57%
1 Year Return
+34.32%
3 Year Return
+92.3%
5 Year Return
+128.17%
10 Year Return
+279.79%
AUM
$5.81B
AUM Growth
+$1.3B
(+29%)
Cap. Flow
+$827M
Cap. Flow
% of AUM
14.25%
Top 10 Holdings %
Top 10 Hldgs %
27.87%
Holding
1,608
New
576
Increased
221
Reduced
201
Closed
609
Top Buys
| 1 |
NVIDIA
NVDA
|
+$339M |
| 2 |
Apple
AAPL
|
+$306M |
| 3 |
UnitedHealth
UNH
|
+$175M |
| 4 |
Microsoft
MSFT
|
+$153M |
| 5 |
Netflix
NFLX
|
+$120M |
Top Sells
| 1 |
Canadian National Railway
CNI
|
+$219M |
| 2 |
Broadcom
AVGO
|
+$213M |
| 3 |
Canadian Natural Resources
CNQ
|
+$113M |
| 4 |
Materials Select Sector SPDR Fund
XLB
|
+$99.2M |
| 5 |
Toronto Dominion Bank
TD
|
+$86.3M |
Sector Composition
| 1 | Technology | 28.21% |
| 2 | Financials | 14.38% |
| 3 | Healthcare | 10.22% |
| 4 | Communication Services | 7.09% |
| 5 | Consumer Discretionary | 5.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
976
Caesarstone
CSTE
$49.8M
| $35.9K | ﹤0.01% |
+18,340
| New | +$35.9K |
|
977
Protara Therapeutics
TARA
$122M
| $35.2K | ﹤0.01% |
+11,591
| New | +$35.2K |
|
978
Outlook Therapeutics
OTLK
$49.3M
| $34.8K | ﹤0.01% |
+21,683
| New | +$34.8K |
|
979
TScan Therapeutics
TCRX
$102M
| $32.9K | ﹤0.01% |
+22,500
| New | +$32.9K |
|
980
Olaplex Holdings
OLPX
$954M
| $32.2K | ﹤0.01% |
23,108
-29,189
| -56% | -$40.7K |
|
|
FSP
981
Franklin Street Properties
FSP
$175M
| $30.7K | ﹤0.01% |
+18,620
| New | +$30.7K |
|
982
Lucid Diagnostics
LUCD
$109M
| $28.7K | ﹤0.01% |
+24,917
| New | +$28.7K |
|
983
Arbe Robotics
ARBE
$147M
| $28.6K | ﹤0.01% |
+16,023
| New | +$28.6K |
|
|
NIPG
984
NIP Group Inc. American Depositary Shares
NIPG
$113M
| $28.5K | ﹤0.01% |
+11,782
| New | +$28.5K |
|
985
Werewolf Therapeutics
HOWL
$65.8M
| $28K | ﹤0.01% |
+25,791
| New | +$28K |
|
986
Rackspace Technology
RXT
$342M
| $26.5K | ﹤0.01% |
+20,605
| New | +$26.5K |
|
987
Acrivon Therapeutics
ACRV
$49.1M
| $26.3K | ﹤0.01% |
+22,175
| New | +$26.3K |
|
988
MacroGenics
MGNX
$104M
| $25.7K | ﹤0.01% |
+21,105
| New | +$25.7K |
|
989
PSQ Holdings
PSQH
$91.8M
| $22.7K | ﹤0.01% |
+11,066
| New | +$22.7K |
|
990
Castellum
CTM
$103M
| $22.2K | ﹤0.01% |
+21,089
| New | +$22.2K |
|
991
OmniAb
OABI
$226M
| $21.3K | ﹤0.01% |
+12,258
| New | +$21.3K |
|
992
C4 Therapeutics
CCCC
$191M
| $19.3K | ﹤0.01% |
13,547
-2,462
| -15% | -$3.51K |
|
993
Companhia Siderúrgica Nacional
SID
$1.97B
| $16.1K | ﹤0.01% |
+11,542
| New | +$16.1K |
|
994
Village Farms International
VFF
$286M
| $15.9K | ﹤0.01% |
+14,510
| New | +$15.9K |
|
995
Zura Bio
ZURA
$137M
| $15.8K | ﹤0.01% |
+15,158
| New | +$15.8K |
|
996
Cerus
CERS
$240M
| $15.5K | ﹤0.01% |
10,997
-9,203
| -46% | -$12.9K |
|
997
Pyxis Oncology
PYXS
$117M
| $13.6K | ﹤0.01% |
+12,334
| New | +$13.6K |
|
|
RAY
998
Raytech Holding Ltd
RAY
$24.6M
| $13.4K | ﹤0.01% |
+11,351
| New | +$13.4K |
|
999
GrowGeneration
GRWG
$92M
| $9.76K | ﹤0.01% |
+10,353
| New | +$9.76K |
|
1000
Texas Instruments
TXN
$167B
| – | – |
-79,080
| Closed | -$14.2M |
|